Alik Farber, MD
Professor, Surgery
Biography
Dr. Farber is a graduate of Brown University and obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at the Southern Illinois School of Medicine. In addition to his role as Division Chief of Vascular and Endovascular Surgery, Dr. Farber is also Medical Director of BMC’s Catheterization and Angiography Laboratories and Co-Director of BMC’s Vascular Non-invasive Laboratory as well as Associate Chair for Clinical Operations in the Department of Surgery. He is a fellow in the American College of Surgeons and is a member of the American Board of Surgery. He is a member of many national and regional medical and surgical societies, including the Society for Vascular Surgery, where he was elected to distinguished fellow status in 2013, the Society of University Surgeons, the Western Vascular Surgery Society, the New England Society for Vascular Surgery, the International Society for Endovascular Surgery, and the Society for Clinical Vascular Surgery. Dr. Farber has served as a principal investigator in a number of clinical trials and is currently a National Co-Chair of the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia), a $25 million grant awarded by the National Institutes of Health (NIH), to conduct a four-year, randomized clinical trial comparing traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia (CLI). He has written and published many articles about vascular and endovascular surgery, has served as a moderator for various vascular meetings, and developed a formal education program in vascular surgery while at Cedar-Sinai Medical Center in Los Angeles, CA, which resulted in the Golden Apple Teaching Award for teaching and mentoring residents. Since his arrival at BMC, Dr. Farber has made it his goal and mission to foster continued clinical excellence and academic productivity. He is currently the director of a fourth year medical school elective (BMC Surgery Bootcamp) which is designed to prepare medical students who are going into surgical internship.
Other Positions
- Section Chief, Vascular and Endovascular Surgery, Surgery, Boston University Chobanian & Avedisian School of Medicine
- Professor, Vascular & Interventional, Radiology, Boston University Chobanian & Avedisian School of Medicine
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
Education
- Harvard Medical School, MD
- Brown University, BS
Publications
- Published on 4/9/2023
Levin SR, Farber A, Kobzeva-Herzog A, King EG, Eslami MH, Garg K, Patel VI, Rockman CB, Rybin D, Siracuse JJ. Postoperative Disability and One-Year Outcomes for Patients Suffering a Stroke after Carotid Endarterectomy. J Vasc Surg. 2023 Apr 09. PMID: 37040850.
Read at: PubMed - Published on 3/30/2023
Shishehbor MH, Powell RJ, Montero-Baker MF, Dua A, Martínez-Trabal JL, Bunte MC, Lee AC, Mugglin AS, Mills JL, Farber A, Clair DG. Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia. N Engl J Med. 2023 Mar 30; 388(13):1171-1180. PMID: 36988592.
Read at: PubMed - Published on 3/30/2023
Shishehbor MH, Powell RJ, Montero-Baker MF, Dua A, Martínez-Trabal JL, Bunte MC, Lee AC, Mugglin AS, Mills JL, Farber A, Clair DG. Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia. N Engl J Med. 2023 Mar 30; 388(13):1171-1180. PMID: 36988592.
Read at: PubMed - Published on 3/30/2023
Farber A, Rosenfield K, Menard MT. Clinical trials in chronic limb-threatening ischaemia. Br J Surg. 2023 Mar 30; 110(4):397-398. PMID: 36638367.
Read at: PubMed - Published on 3/22/2023
Shaikh SP, Haqqani MH, Alfson DB, Forsyth A, Brea F, Richman A, Siracuse JJ, Rybin D, Eberhardt RT, Farber A, Brahmbhatt TS. Outcomes following ipsilateral great saphenous vein bypass for lower extremity arterial injuries. Injury. 2023 Mar 22. PMID: 36973136.
Read at: PubMed - Published on 3/22/2023
Shaikh SP, Haqqani MH, Alfson DB, Forsyth A, Brea F, Richman A, Siracuse JJ, Rybin D, Eberhardt RT, Farber A, Brahmbhatt TS. Outcomes following ipsilateral great saphenous vein bypass for lower extremity arterial injuries. Injury. 2023 Mar 22. PMID: 36973136.
Read at: PubMed - Published on 3/16/2023
Farber A, Rosenfield K, Menard MT. Surgery or Endovascular Therapy for Chronic Limb Ischemia. Reply. N Engl J Med. 2023 Mar 16; 388(11):e37. PMID: 36920772.
Read at: PubMed - Published on 1/13/2023
Haqqani MH, Alonso A, Kobzeva-Herzog A, Farber A, King EG, Meltzer AJ, Eslami MH, Garg K, Rybin D, Siracuse JJ. Variations in Practice Patterns for Peripheral Vascular Interventions Across Clinical Settings. Ann Vasc Surg. 2023 May; 92:24-32. PMID: 36642163.
Read at: PubMed - Published on 1/6/2023
Menard MT, Rosenfield K, Farber A. The BEST-CLI Trial: Implications of the Primary Results. Eur J Vasc Endovasc Surg. 2023 Mar; 65(3):317-319. PMID: 36621707.
Read at: PubMed - Published on 12/15/2022
Sung E, Levin SR, Kariveda R, Farber A, King EG, Cheng TW, Siracuse JJ. Hemodialysis Access Outcomes for Patients with Unstable Housing. J Am Coll Surg. 2023 Jan 01; 236(1):118-124. PMID: 36398338.
Read at: PubMed
View 319 more publications: View full profile at BUMC